Listen on the go
CORRECT!
Next question
touchENDOCRINOLOGY touchENDOCRINOLOGY

Start Learning

Touch Loading image
Research highlights disparities in liver transplants for non-cancer conditions
JOURNALS
Start Learning
Low anti-Müllerian hormone levels tied to fatty liver risk in women: Findings from the CARDIA study
Tirzepatide reduces risk of developing T2D by over 90% in individuals with obesity and prediabetes over 3 years
JOURNALS
Start Learning
Tirzepatide reduces risk of developing T2D by over 90% in individuals with obesity and prediabetes
Human Internal Digestive Organs Pancreas with Gallbladder Anatomy
JOURNALS
Start Learning
Efficacy and Safety of Early Initiation of Sodium–Glucose Co-transporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-analysis
Endometriosis and Uterine Diseases
JOURNALS
Start Learning
The 11th Annual SEUD Congress: Modern Management of Endometriosis and Uterine Diseases
touchMDT
Start Learning
Navigating diagnosis, monitoring, and early treatment in achondroplasia: Multidisciplinary insights from specialist obstetricians and paediatricians
CE/CME ACCREDITED
touchMDT
Start Learning
Empowering T2D management: The evolution of basal insulin therapy
CE/CME ACCREDITED
JOURNALS
Start Learning
EASO release new framework for the diagnosis, staging and management of obesity in adults
CONFERENCE HUB
Start Learning
Benefits of finerenone for patients with type 2 diabetes, cardiovascular, kidney and metabolic complications
JOURNALS
Start Learning
Addressing liver health disparities in rural areas: A global conversation
JOURNALS
Start Learning
Expert Q&A: Prof. Pappachan on career success and innovations in endocrinology

to view Favourites, Keep Notes and Track CME Credits

Favourites
Teprotumumab’s Impact on Proptosis in Long-duration Thyroid Eye Disease: A Systematic Review and Meta-analysis
View
Clinical and Biochemical Profiles of Hospitalized Patients with Hypercalcaemia from a Tertiary Care Centre in North India
View
Diabetes Care and Education: A Look Backward and Forward
View
Benefits of finerenone for patients with type 2 diabetes, cardiovascular, kidney and metabolic complications
View
ATTD 2025: Key Breakthroughs in Diabetes Technology and Treatment
View
The path from detection to personalized long-term care for Fabry disease
View
Use of Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes
View
MiniMed 780G safe and effective for children 2-6 years with type 1 diabetes
View
Empowering T2D management: The evolution of basal insulin therapy
View
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup